(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺 性质
沸点 | 588.8±50.0 °C(Predicted) |
---|---|
密度 | 1.32 |
储存条件 | Store at -20°C |
溶解度 | DMSO:50 mg/mL(178.37 mM;需要超声波和加热)H2O:< 0.1 mg/mL(不溶) |
形态 | 粉末 |
酸度系数(pKa) | 11.13±0.20(Predicted) |
颜色 | 白色至米白色 |
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺 用途与合成方法
ROCK 3.6 nM (IC 50 ) |
PKC 420 nM (IC 50 ) |
CaMKII 810 nM (IC 50 ) |
Y-33075 (Y-39983) is a potent ROCK inhibitor, with an IC 50 of 3.6 nM. Y-33075 also inhibits PKC and CaMKII more potently than Y-27632, and the IC 50 s of Y-27632 and Y-33075 for PKC are 9.0 μM and 0.42 μM, respectively, whereas the IC 50 s of Y-27632 and Y-33075 for CaMKII are 26 μM and 0.81 μM, respectively. The IC 50 s of Y-27632 and Y-33075 for PKC is 82 and 117 times those for ROCK, respectively, whereas the IC 50 s of Y-27632 and Y-33075 for CaMKII is 236 and 225 times those for ROCK, respectively. Y-33075 (Y-39983, 10 μM) extends neurites in the retinal ganglion cells (RGCs) compared with those in RGCs treated without Y-39983. Y-33075 (Y-39983, 1 μM) inhibits the contraction of rabbit ciliary artery segments evoked by histamine in Ca 2+ -free solutions. Y-33075 (10 μM) shows no effect on the [Ca 2+ ]i increase with the high-potassium (high-K) solution.
In rabbits, Y-39983 (≥0.01%) significantly lowers intraocular pressure (IOP) at 2 hours after topical administration. In monkeys, Y-39983 (0.05%)-treated eyes show significant reduction of IOP between 2 and 7 hours after topical administration. Y-39983 (100 μM) increases the regenerating axons of retinal ganglion cells (RGCs) in the eyes of the rats.
(R)-4-(1-氨基乙基)-N-1H-吡咯并[2,3-B]吡啶-4-基苯甲酰胺 价格(试剂级)
更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
---|---|---|---|---|---|
2024-11-08 | HY-10067 | 1 mg | 726 | ||
2024-11-08 | HY-10067 | 5 mg | 1598 |